Nordson Raises Full-Year Guidance After Record Q3: Sales Up 10%, Adjusted EPS $3.25
NDSN sits 47% above its 52-week low of $213.23.
Summary
Nordson reported record Q3 FY2026 results with sales up 10% to $818M and adjusted EPS of $3.25, beating guidance. The company raised full-year sales and EPS guidance on a 35% backlog increase.
Key Events · Earnings and Guidance · NDSN
-
Record Q3 Sales and EPS
Sales reached an all-time quarterly record of $818 million, up 10% year-over-year. Adjusted EPS was $3.25, up 19% and above the high end of guidance.
-
Full-Year Guidance Raised
Company now expects FY2026 sales of $3,035–$3,075 million and adjusted EPS of $11.80–$12.00, up from prior guidance, driven by strong order entry and backlog.
-
Backlog Up 35%
Backlog increased 35% compared to the prior year, indicating sustained demand momentum entering Q4.
-
Segment Strength Broad-Based
All three segments posted record sales. Advanced Technology Solutions grew 28% with EBITDA up 58%; Medical and Fluid Solutions sales rose 5% with EBITDA up 6%.
Analysis · NDSN · Technology
Nordson delivered record Q3 results with sales of $818 million, up 10% year-over-year, and adjusted EPS of $3.25, beating the high end of guidance. The company raised full-year sales guidance to $3.035–$3.075 billion and adjusted EPS to $11.80–$12.00, driven by a 35% increase in backlog. All three segments posted record sales, with Advanced Technology Solutions leading at 28% growth. The stock trades near its 52-week high, and this earnings beat with raised guidance confirms strong momentum across diversified end markets.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.7% of the 1072 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.61%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NDSN was trading at $313.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $17.3B. The 52-week trading range was $213.23 to $315.68. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.